Valion Bio, Inc. Common Stock (NASDAQ: VBIO) last traded at $0.123, up 0.41% on the session. The quote above updates while this page is open; the figures below are drawn from Valion Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Valion Bio, Inc. Common Stock trades on NASDAQ under the ticker VBIO. Its market capitalisation is $2.72 million.
Valuation measures for Valion Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.72M |
|---|---|
| Enterprise value | $21.20M |
| Price / sales | 5.64 |
| Price / book | 0.64 |
| Beta | 1.28 |
Trailing-twelve-month figures tagged in Valion Bio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $482.0K |
|---|---|
| Net income (TTM) | -$18.75M |
| Gross margin | -58.09% |
| Operating margin | -3506.43% |
| Return on equity | -441.59% |
| Cash | $2.11M |
Range and volume for VBIO over the past 52 weeks.
| 52-week high | $3.21 |
|---|---|
| 52-week low | $0.112 |
| Volume | 3.75M |
| Average volume | 6.77M |
| Previous close | $0.122 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.